| Scientific News - CNIO - page 5

Home | News | Scientific News | Page 5

Scientific News

Scientific News
Cell Death & Differentiation. CNIO researchers show that targeting telomeres might be an effective therapeutic strategy against lung cancer Healthy cells can only divide a limited number of times during an organism’s lifetime. In...
Scientific News
Pharmaceutics. CNIO researchers analyse how the Spanish population responds to common drugs according to their genetics The study that analyses the impact of genetics among the Spanish population in their response to...
Scientific News
Cancer Communications. The search for the origin of a rare tumor points to a poorly studied mechanism as a new would-be hot topic in cancer research: ‘succinylation’ Researchers at the CNIO (Spanish National Cancer Research Center) have discovered that one of the...
Scientific News
Nature. Researchers identify a strategy used by cancer cells to resist chemotherapy  Chemotherapy is still the most widely used treatment for advanced cancer. But tumors often become...
Scientific News
CNIO researchers help to understand the functioning of the protein that makes DNA loops in the human genome At the end of the 1990s, Ana Losada, a researcher at the Spanish National Cancer Research Centre...
Scientific News
A major European project involving CNIO seeks to detect pancreatic cancer in its early stages through a blood test Pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer, is usually...
Scientific News
Scientists identify the mechanisms leading to resistance to lung cancer treatment with Sotorasib, the first KRAS inhibitor According to recent figures published by the Spanish Society of Medical Oncology (SEOM), more than...
Scientific News
CNIO researchers collect samples from cabin crew members to investigate the relationship between cancer and jet lag Our body’s circadian rhythm is “the biological clock that allows us to adapt to an...
CNIO researchers propose biomarkers to select breast cancer patients who could benefit from denosumab treatment The drug denosumab is currently used to treat osteoporosis and bone metastases. For more than a...